Page 27 - Eceptor News Today

An international team of researchers has demonstrated that a combination of inhibitors may suppress tumor growth and prevent relapse in patients with certain cancers, including head and neck squamous cell carcinoma and lung adenocarcinoma.

A recent Scientific Reports study investigated the effect of yoga on rheumatoid arthritis (RA) severity.

A recent study evaluated the safety and efficacy of the GBP510 vaccine against SARS-CoV-2 infection.

In recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have been highly successful and have become an important basis for the future treatment of cancers.

Researchers who previously developed the first 3D human cell culture models of Alzheimer's disease (AD) that displays two major hallmarks of the condition-;the generation of amyloid beta deposits followed by tau tangles-;have now used their model to investigate whether the exercise-induced muscle hormone irisin affects amyloid beta pathology.

The immunotherapy drug, durvalumab, has been the standard of care for patients with stage III non-small cell lung cancer(NSCLC) to improve survival, when prescribed after chemotherapy and radiation therapy.

Researchers described the detection of a human interleukin-1β antagonist with low molecular weight that disrupts interactions with the interleukin-1 receptor type I receptor.

European Medicines Agency reviews GLP-1 receptor agonists, including Ozempic, Saxenda and Wegovy, due to Icelandic patients reporting thoughts of suicide. The U.S. has not launched a similar probe.

Groundbreaking research published today in Nature Genetics describes the largest-ever study into the genetics of random "round-the-clock" blood glucose levels.

The interaction of caffeine with Leucine rich repeat kinase 2 (LRRK2) genetic risk variants in Asians.